Therapeutic Target-Humanized Mice
Cre/Dre-Driver Mice
Immunodeficient NMG Mice
Strain Name：SNU-182 Strain State ： Validation of tumorigenic capacity | Cat. NO.：NM-G09
human liver cancer cell line
Strain Name：UM-UC-3 Strain State ： Validation of tumorigenic capacity | Cat. NO.：NM-P04
human bladder cancer cell line
Strain Name：LS1034 Strain State ： Construction | Cat. NO.：NM-J17
human colon cancer cell
Strain Name：VCaP Strain State ： Validation of tumorigenic capacity | Cat. NO.：NM-Q06
human prostate cancer cell line
Strain Name：SW948 Strain State ： Construction | Cat. NO.：NM-J15
Strain Name：MRC-5 Strain State ： Construction | Cat. NO.：NM-FX11
human lung cancer cell line
Strain Name：HPAF-II Strain State ： Construction | Cat. NO.：NMC-240404
human pancreatic cancer cell line
Strain Name：KrasG12D/Mki67-e(2A-tdtomato-2A-AKaluciferase) Strain State ： Validation of target gene expression completed | Cat. NO.：NM-YD10
derived from lung cancer model of the offspring produced by mating Mki67-tdTomato-2A-Luc (NM-KI-200223) and Kras-LSL-G12D mice (NM-KI-190003) infected by AAV-Cre virus
Strain Name：ID8 Strain State ： Validation of tumorigenic capacity | Cat. NO.：NM-X04A
mouse ovarian epithelial cancer cell line
Strain Name：A2780 Strain State ： Validation of tumorigenic capacity completed | Cat. NO.：NM-RC02
The A2780 human ovarian cancer cell line was established from tumor tissue from an untreated patient with ovarian endometroid adenocarcinoma.
Please fill in the order form and we will contact you within 2 working days.
